Cite
HARVARD Citation
Judd, J. et al. (2017). Immune‐Related Adverse Events as a Biomarker in Non‐Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors. Oncologist. pp. 1232-1237. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Judd, J. et al. (2017). Immune‐Related Adverse Events as a Biomarker in Non‐Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors. Oncologist. pp. 1232-1237. [Online].